Latest debt-to-equity ratio
Amylyx Pharmaceuticals Debt-to-equity ratio
Direct answer
Amylyx Pharmaceuticals's debt-to-equity ratio is 2.2%.
The verified market snapshot reports 2.2%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 24, 2026.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.2%
Explore related company data
View Amylyx Pharmaceuticals's market capitalizationView Amylyx Pharmaceuticals's price-to-book ratioView Amylyx Pharmaceuticals's return on equityView Amylyx Pharmaceuticals's 52-week price rangeView Amylyx Pharmaceuticals's profit marginView all Amylyx Pharmaceuticals key metricsReturn to Amylyx Pharmaceuticals profile